{"nct_id":"NCT03742895","title":"Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2018-12-12","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}